Transce3nd’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Transce3nd’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13	Closed	-$2.1K	–	467
2025 Q2	$2.1K	Sell	13 -5	-28%	-$796	﹤0.01%	879
2025 Q1	$3.06K	Buy	18 +1	+6%	+$174	﹤0.01%	809
2024 Q4	$2.83K	Buy	+17	New	+$2.9K	﹤0.01%	1055

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Transce3nd's FBT Position: Q3 2025 in Review

Transce3nd sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2025, closing a stake of 13 shares — an estimated $2.1K sold.

Transce3nd first reported a position in FBT in Q4 2024 and held it in 3 quarters. The position peaked at $3.06K in Q1 2025. 253 funds tracked by Wall St. Rank hold FBT as of Q3 2025.

Transce3nd reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 13 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2025, an estimated $2.1K.
Transce3nd first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and held it in 3 quarters.
Transce3nd's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.06K in Q1 2025.
253 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.